Jongsma AP - Search Results

1

Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.

Bergman AM, Pinedo HM, Jongsma AP, Brouwer M, Ruiz van Haperen VW, Veerman G, Leyva A, Eriksson S, Peters GJ. Bergman AM, et al. Among authors: jongsma ap. Biochem Pharmacol. 1999 Feb 15;57(4):397-406. doi: 10.1016/s0006-2952(98)00318-9. Biochem Pharmacol. 1999. PMID: 9933028

2

Isolation and characterization of subclones of L1210 murine leukemia with different sensitivities to various cytotoxic agents.

Brouwer M, Smets LA, Jongsma AP. Brouwer M, et al. Among authors: jongsma ap. Cancer Res. 1983 Jun;43(6):2884-8. Cancer Res. 1983. PMID: 6850600

3

Serum-dependent "cannibalism" and autodestruction in cultures of human small cell carcinoma of the lung.

Brouwer M, de Ley L, Feltkamp CA, Elema J, Jongsma AP. Brouwer M, et al. Among authors: jongsma ap. Cancer Res. 1984 Jul;44(7):2947-51. Cancer Res. 1984. PMID: 6327030

4

Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.

Piek JM, Verheijen RH, Menko FH, Jongsma AP, Weegenaar J, Gille JJ, Pals G, Kenemans P, van Diest PJ. Piek JM, et al. Among authors: jongsma ap. Histopathology. 2003 Jul;43(1):26-32. doi: 10.1046/j.1365-2559.2003.01654.x. Histopathology. 2003. PMID: 12823709

5

Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.

Jongsma AP, Piek JM, Zweemer RP, Verheijen RH, Klein Gebbinck JW, van Kamp GJ, Jacobs IJ, Shaw P, van Diest PJ, Kenemans P. Jongsma AP, et al. Mol Pathol. 2002 Oct;55(5):305-9. doi: 10.1136/mp.55.5.305. Mol Pathol. 2002. PMID: 12354934 Free PMC article.

6

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, Gille JJ, Jongsma AP, Pals G, Kenemans P, Verheijen RH. Piek JM, et al. Among authors: jongsma ap. J Pathol. 2001 Nov;195(4):451-6. doi: 10.1002/path.1000. J Pathol. 2001. PMID: 11745677

7

Evaluating limited specificity of drug pumps reduced relative resistance in human MDR phenotypes.

Jongsma AP, Riethorst A, Lankelma J, Dekker H, Westerhoff HV. Jongsma AP, et al. Eur J Biochem. 2000 Sep;267(17):5369-77. doi: 10.1046/j.1432-1327.2000.01560.x. Eur J Biochem. 2000. PMID: 10951194 Free article.

8

Relating multidrug resistance phenotypes to the kinetic properties of their drug-efflux pumps.

Westerhoff HV, Riethorst A, Jongsma AP. Westerhoff HV, et al. Among authors: jongsma ap. Eur J Biochem. 2000 Sep;267(17):5355-68. doi: 10.1046/j.1432-1327.2000.01559.x. Eur J Biochem. 2000. PMID: 10951193 Free article.

9

Energy, control and DNA structure in the living cell.

Wijker JE, Jensen PR, Snoep JL, Vaz Gomes A, Guiral M, Jongsma AP, de Waal A, Hoving S, van Dooren S, van der Weijden CC, et al. Wijker JE, et al. Among authors: jongsma ap. Biophys Chem. 1995 Jun-Jul;55(1-2):153-65. doi: 10.1016/0301-4622(94)00148-d. Biophys Chem. 1995. PMID: 7632875 Review.

10

Tissue distribution of the human MDR3 P-glycoprotein.

Smit JJ, Schinkel AH, Mol CA, Majoor D, Mooi WJ, Jongsma AP, Lincke CR, Borst P. Smit JJ, et al. Among authors: jongsma ap. Lab Invest. 1994 Nov;71(5):638-49. Lab Invest. 1994. PMID: 7734012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page